Samil Pharmaceutical Co.,Ltd (KRX:000520)
South Korea · Delayed Price · Currency is KRW 7,400.00
+310.00 (4.37%)
Last updated: Jun 4, 2026, 2:24 PM KST
KRX:000520 Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -36,417 | -34,664 | -5,629 | 1,664 | -28.29 | -5,347 |
Depreciation & Amortization | 9,320 | 9,197 | 7,263 | 5,368 | 4,989 | 4,712 |
Loss (Gain) From Sale of Assets | 17.28 | -1.14 | 30.28 | -1,893 | -463.24 | -365.84 |
Asset Writedown & Restructuring Costs | 1,685 | 1,685 | - | - | - | - |
Loss (Gain) From Sale of Investments | 229.35 | 229.35 | - | 585 | 7.11 | - |
Loss (Gain) on Equity Investments | -53.7 | -0.53 | -0.42 | -0.49 | -0.37 | - |
Provision & Write-off of Bad Debts | 1,021 | 1,073 | 1,492 | -1,187 | 773.39 | 476.66 |
Other Operating Activities | 17,500 | 16,045 | 7,486 | 7,976 | 8,526 | 7,130 |
Change in Accounts Receivable | 4,180 | 2,322 | -2,112 | -446.53 | -3,783 | -1,151 |
Change in Inventory | 4,241 | -887.69 | -3,133 | -7,914 | -644.11 | -181.39 |
Change in Accounts Payable | 745.26 | 89.47 | -2,014 | 7,295 | 5,131 | -2,278 |
Change in Other Net Operating Assets | 8,571 | 5,481 | -791.29 | 298.63 | -10,354 | -1,578 |
Operating Cash Flow | 11,040 | 568.16 | 2,590 | 11,746 | 4,154 | 1,417 |
Operating Cash Flow Growth | - | -78.06% | -77.95% | 182.76% | 193.18% | -81.78% |
Capital Expenditures | -10,154 | -7,457 | -5,372 | -24,244 | -48,481 | -32,828 |
Sale of Property, Plant & Equipment | 10.01 | 4.54 | 39.36 | 5,213 | 272.79 | 538.32 |
Sale (Purchase) of Intangibles | -144.52 | -66.29 | -240.55 | -91.65 | -175.67 | 217.13 |
Investment in Securities | -500.18 | -299.98 | -750 | -585 | 11,262 | -9,800 |
Other Investing Activities | -502.44 | -150.32 | -38.78 | -69.61 | 1,186 | -3,436 |
Investing Cash Flow | -11,291 | -7,969 | -6,361 | -19,778 | -35,936 | -45,308 |
Short-Term Debt Issued | - | 22,523 | 22,499 | 7,005 | 377.14 | 6,613 |
Long-Term Debt Issued | - | 16,548 | 52,599 | 31,908 | 77,479 | 34,997 |
Total Debt Issued | 59,808 | 39,071 | 75,098 | 38,913 | 77,856 | 41,609 |
Short-Term Debt Repaid | - | -18,888 | -58,771 | -8,612 | -30,993 | -2,980 |
Long-Term Debt Repaid | - | -4,896 | -850.33 | -14,214 | -14,279 | -1,431 |
Total Debt Repaid | -52,490 | -23,783 | -59,622 | -22,827 | -45,272 | -4,412 |
Net Debt Issued (Repaid) | 7,317 | 15,288 | 15,476 | 16,086 | 32,584 | 37,198 |
Repurchase of Common Stock | - | - | - | - | - | -2,492 |
Dividends Paid | - | - | - | - | -1,001 | -938.64 |
Other Financing Activities | -7,125 | -6,638 | -7,494 | -7,603 | -1,877 | -1,893 |
Financing Cash Flow | 192.58 | 8,650 | 7,982 | 8,483 | 29,706 | 31,874 |
Foreign Exchange Rate Adjustments | 171.18 | 25.56 | 20.14 | -1,448 | -12.81 | 11.66 |
Miscellaneous Cash Flow Adjustments | -0 | -0 | 0 | - | - | - |
Net Cash Flow | 112.87 | 1,275 | 4,231 | -997.32 | -2,089 | -12,005 |
Free Cash Flow | 886.22 | -6,888 | -2,782 | -12,498 | -44,327 | -31,411 |
Free Cash Flow Margin | 0.42% | -3.28% | -1.27% | -6.37% | -24.67% | -23.40% |
Free Cash Flow Per Share | 41.71 | -324.47 | -154.68 | -864.01 | -3179.28 | -2271.39 |
Cash Interest Paid | 7,125 | 6,638 | 7,444 | 7,573 | 1,877 | 1,893 |
Cash Income Tax Paid | 1,701 | 2,088 | 3,547 | 1,832 | -36.65 | 2,438 |
Levered Free Cash Flow | -334.45 | -6,759 | -8,442 | -27,525 | -37,685 | -33,164 |
Unlevered Free Cash Flow | 5,111 | -1,277 | -5,281 | -25,310 | -35,020 | -29,287 |
Change in Working Capital | 17,737 | 7,004 | -8,051 | -766.85 | -9,650 | -5,189 |